Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Abbott enters mitral valve replacement market via $250mm Tendyne buy

Executive Summary

Abbott Laboratories Inc. acquired the portion of private device company Tendyne Holdings Inc. (minimally invasive mitral valve replacement therapies) that it doesn’t already own, paying $225mm in cash up front, and a potential $25mm in earn-outs contingent on regulatory milestones.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register